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Abstract 
Alzheimer’s disease is the leading cause of dementia in the United States. The 
neurodegenerative condition of this disease correlates with the formation in the brain of 
plaques consisting of insoluble protein aggregates, termed amyloid. The aggregates are 
caused by the misfolding of amyloid β, a 40–42 amino acid polypeptide that is naturally 
occurring in all humans. One approach to preventing the amyloid cytotoxicity is to 
prevent the formation of plaques altogether. Many types of inhibitors have been tested for 
their therapeutic value, including substituted peptide strands. In this study, the inhibitory 
potential of two such peptides was tested: methylated peptides and nitrile-substituted 
peptides. Aβ(16-22) was used for its fiber-forming properties, and x-ray diffraction and 
transmission electron microscopy were used to assess the extent of fibrillogenesis. The 
methylated peptide effectively inhibited fiber formation as previously recorded, and the 
cyanophenylalanine derivatives did not form fibers. The latter experiment provided 
insight on the structural and folding properties of Aβ more than its possible inhibitory 
potential. 
 
Key words: protein, amyloid, methylation, cyanophenylalanine, x-ray diffraction, 
electron microscopy 
 
 
 
 
 
 
 
 
 
 
 
 
 - 2 - 
Table of Contents 
 
1. Introduction……………………………………………………………….3 
 
2. Methods……………………………......………………………………….8 
 
3. Results………….……………………………………………..…………10 
 
4. Discussion……………………………………………………………….12 
 
5. Conclusion.……….……………………………………………………..15 
 
6. References……………….………………………………………………16 
 
7. Figures………….………………………………………………………..18    
 
 
 
 
 
 - 3 - 
Introduction 
Alzheimer’s Disease is a neurodegenerative disease that affects millions of people 
every year. One of the causative agents of AD is the fibrillogenesis of β-amyloid, a 42-
strand protein cleaved from amyloid precursor protein (1). Research for AD prevention or 
for therapeutics normally stem from: inhibition of Aβ expression or fibrillogenesis, 
inhibition of the proteases that cleave Aβ from APP, and alleviating disease symptoms by 
methods unrelated to amyloidosis, such as trying to re-grow killed cells or enhance the 
remaining cells (2). Since APP is a naturally occurring protein, and the secretases that 
cleave it to form Aβ are proven to have other biologically significant roles, the inhibition 
of the secretases is not a viable option, nor is preventing expression of Aβ (3). Though 
medications that enhance synaptic efficiency are now the only therapeutic avenue 
available to those with AD, their efficacy is limited. All treatments that minister to the 
symptoms but not the etiological pathway will run into this hurdle since the neurons will 
continue to die in the presence of the cytotoxic protein species. Also, research in such 
uniquely Aβ pathways and effects can not directly provide information about other 
amyloid diseases. Since it is likely that any polypeptide chain can aggregate into 
insoluble fibrils, and amyloid disease affect several different parts of the body, an avenue 
that can apply to inhibition of fibrillogenesis, as opposed to only Aβ, would be beneficial. 
(4). Therefore, the principal research for AD therapeutics should be the prevention or 
control of Aβ fibrillogenesis and its toxic form (3).  
There has been much debate over which form of the Aβ peptide is responsible for 
neuronal death. The “amyloid hypothesis” originally assumed that the insoluble fiber was 
the guilty agent. The fiber exhibits characteristic Congo Red binding properties, a trait 
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manipulated in many early amyloid experiments. Since the presence of fibers was 
confirmed in this way in the autopsied brains of those with AD, it was hypothesized that 
they caused the cell death. Later studies showed that the oligomeric form of the peptide is 
in equilibrium with the fibers (4), something not seen because the oligomer does not 
exhibit green birefringence when stained with Congo Red like the fiber. Recently the 
toxic effect of the oligomeric form has been shown in vitro in cell culture. This evidence 
does not mean the insoluble fiber is necessarily innocuous, and in the case of therapeutics 
it would be beneficial to consider them both dangerous. Uncertainty as to which form is 
toxic presents concerns for those seeking to prevent Aβ fibrillogenesis. Driving the 
oligomeric form to stabilize may cause harmful fibers to form, and disassembling the 
formed fiber may cause harmful oligomers to form. Also, in an extreme case, the fibers 
may temper the effects of the toxic oligomers by sequestering them and shielding healthy 
neurons. The goal, therefore, must be to prevent misfolding and induce the native 
structure, or to form stable, innocuous monomers or dimers that can be broken down by 
the body (5). How to reach this goal takes knowledge of the folding properties of Aβ. 
Though the pathway is unclear, the structure of the formed amyloid fiber has been 
studied for over twenty years. Hydrogen bonds bring amino acid strands together to form 
sheets, the side chains of which then interact to form the fiber. All fibers share a cross-β 
sheet pattern (6), the peptide chains running perpendicular to the long axis of the fiber 
and the hydrogen bonding running parallel. This creates a fiber of indefinite length (7). 
Fibril formation begins with the slow formation of a nucleus, which then quickly 
propagates (8). The driving force of aggregation is unknown, but studies show that 
hydrophobic interactions are very influential in folding, with electrostatic interactions 
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playing a lesser role (8, 9). There are two main hydrophobic cores: Aβ(16-22) and 
Aβ(34-42). The disruption of either of these sections prevents fiber formation, but Aβ(16-
22) is the more effective (10) and is assumed to be more important in crystallite 
formation (11). Its importance in fiber formation and its short sequence makes it an 
excellent model for inhibition studies, and for creating a peptide-based inhibitor. It 
stabilizes through rearrangement in the same way Aβ(1-40) is assumed to stabilize, 
meaning the mechanisms for aggregation of the short peptide can used to study and 
understand the mechanisms of the full-length peptide (12). 
There are many different classes of potential fibrillogenesis inhibitors, but one of 
the most rational is peptide-based inhibitors. While other inhibitors can be found through 
educated guesses and chance, peptides can be specifically designed and manipulated. In 
most cases, the peptide used is a short segment from the target amyloidgenic protein. This 
overcomes the problem many small molecules have of affinity, since proteins can in 
general bind to themselves. Several forms of inhibitors have been synthesized, including 
peptides with: amino acid substitutions; insertions of D-amino acids; and modification of 
their backbones, termini, amino acid side chains, and bonds (13). Proline substitutions 
were very common since they alter secondary structure, entering a characteristic ‘kink’ in 
the amino acid folding, but have since been proven ineffective as inhibitors. The ‘kink’ 
that may have been beneficial prevented the inhibitor from binding to the wild type 
strand. D-amino acids were shown to make more effective inhibitors than L-amino acids, 
even on L-amino acid targets. (5) 
Modification of peptide backbones is prevalent in the form of N-methylated 
peptides. In these strands bulky methyl groups replace hydrogens on the nitrogen in the 
 - 6 - 
peptide backbone. Where the methylations are located affects the efficacy of the 
inhibitor. David Gordon et al. (2001) showed that alternating methylations on Aβ(16-22) 
creates a strong inhibitor and disassembler of amyloid fibers. Kokkoni et al (2006) found 
that a methyl group on any one amino acid in a peptide sequence inhibits fibrillogenesis. 
The theory behind N-methylated peptides is that the addition of one methyl group or 
more on one face of the peptide strand forms a two-sided peptide: one that can H-bond 
with the target protein and one that cannot. This prevents propagation and stifles fiber 
growth (5). Another method of inhibition could be steric hindrance. For fiber 
disassembly, it is postulated that the inhibitor binds to the fiber and removes one amino 
acid strand at a time in a more stable conformation, which can then be broken down (14). 
This would explain why such a high ratio of inhibitor to amyloid is needed.  
Another interesting peptide-based inhibitor is cyanophenylalanine, which involves 
the addition of a nitrile group to phenylalanine. Experimental use of cyanophenylalanine 
is becoming more widespread because it is a useful probe for IR and fluorescence 
experiments (15). Because of the hydrophobicity of phenylalanine, it often is present in 
the hydrophobic core of enzymes and other proteins, making it a valuable amino acid to 
follow in the folding process.  In Aβ(16-22), there are two phenylalanines: residues 19 
and 20. By switching which one contains the nitrile group, the individual significance of 
each amino acid in the fibrillogenesis pathway can be assayed.  
 When testing for the efficacy of these two forms of fibrillogenesis inhibitors, it is 
advisable to use more than one assay since each assay provides insight into different 
aspects of the protein and its folding (5). One valuable pair is x-ray diffraction (XRD) 
and electron microscopy (EM) (16). The diffraction pattern of an amyloid fiber is a 
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characteristic cross-β sheet with the hydrogen- bonding direction is reliably around 4.7 Å, 
and the intersheet stacking direction around 10.0 Å (11). Small changes in both hydrogen 
bonding and intersheet stacking, therefore, can be detected through x-ray, and the 
direction of fiber inhibition can be discerned. EM gives visual, morphological support of 
what was deduced from XRD. These two methods are the most reliable when used in 
tandem since the structure of Aβ fibrils does not appear to be determined solely by its 
amino acid sequence or thermodynamics (17) and therefore cannot be deduced by 
computer or other means that rely on these mechanisms. 
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Methods 
 
 Peptides Peptides were received from the lab of Dr. Sean Decatur of Mount 
Holyoke College. They were synthesized, purified by HPLC, and then lyophilized. They 
were then dissolved in 0.05M DCl for six hours for H/D exchange, and lyophilized again. 
This was then dissolved in 1 mM phosphate buffer at pH 7 at a concentration of 10 
mg/mL. The individual peptides were then mixed at the appropriate molar ratio. The 
samples were: Aβ16-22, Aβ16-22 methylated (m), 1:1 molar ratio wild type to inhibitor, 
and 1:5 molar ratio wild type to inhibitor. The second batch of samples was Aβ(16-22) 
with a nitrile substitution on: residue 19, residue 20, or both 19 and 20.  
X-ray Diffraction The peptide solution was aspirated into a 0.7 mm siliconized 
glass capillary tube (Charles A. Supper, Co., South Natick, MA, USA) to a column height 
of approximately 10.0 mm. The narrow end was flame sealed and the wide end sealed 
with wax then punctured with a hot needle to allow for evaporation. They were then 
allowed to dry down vertically at room temperature in a magnetic field until only a 
uniform disk remained.  
The dried sample was taken to the lab of Dr. Andrew Bohm of the Department of 
Biochemistry at Tufts University. Measurements were taken using the Oxford Diffraction 
Xcalibur PX Ultra. The sample was placed 85 mm from the detector, and was exposed to 
x-rays for 150 seconds. The resulting patterns were translated and background subtracted 
using CrysAlis RED software. FIT2D and Peak Fit were then used to create an intensity 
profile, the results of which were then used to determine coherent domain size and lattice 
spacing using Bragg’s Law. 
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 Transmission Electron Microscopy Sample solutions were diluted to 0.5 mg/mL 
and spotted onto a UV- radiated carbon- coated mesh grid for 15 minutes and blotted. 
Once dried, 2% uranyl acetate was placed on the grids for 15 minutes to negatively stain 
them. The grids were blotted and allowed to air dry before searching for fiber formation. 
A Philips CM70 Transmission Electron Microscope at 39,000; 28,500; and 11,500 times 
magnification was used. Pictures were taken on Kodak film. 
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Results 
  
The XRD patterns in Figures 1 and 4 are background subtracted with an empty 
capillary tube. While there are other bands of high electron density, only those 
corresponding to hydrogen bonding and intersheet stacking are analyzed. In Figures 2, 5, 
6, and 7, the D-spacing refers to the distance between strands or polypeptide sheets (for 
hydrogen bonding and intersheet stacking respectively). The coherent length is the 
amount of interactions present, and serves to quantitate the degree of fibrillogenesis. The 
lyophilized samples serve as a baseline for comparison. The error bars in Figure 7 
represent the standard deviations of the samples. 
 Methylation Study The XRD patterns from the four samples show a decrease in 
the amount of amyloid fiber present dependent on the amount of methylated peptide 
(Figure 1). As the amount of inhibitor increases, the bands broaden, particularly the 
intersheet stacking band. While the 1:1 samples are similar to the wild type in the degree 
of intersheet stacking present, the 1:5 ratio samples are significantly lower. Both also 
show a greater distance between sheets caused by side chain interactions. In the 
hydrogen- bonding direction the 1:1 sample has less bonding than the 1:5 sample, but 
neither is significantly different from the wild type (Figures 2, 7). Not enough data could 
be collected from the Aβ(16-22)m XRD sample to be analyzed. 
 In Figure 3, Aβ(16-22) forms fibers morphologically similar to the full-length 
peptide (3: A). They have diameters of approximately 250 Å, and lengths around 15,000 
Å. The presence of Aβ(16-22)m in equal concentration to the wild type alters its 
conformation, causing it to form wide, flat, plate-like fibers (Figure 3: B-D). These fibers 
have widths of approximately 1,600 Å and varying lengths from 8,000 Å to 45,000 Å. 
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 Cyanophenylalanine Study The weakening of peptide interactions is again 
obvious from the XRD patterns (Figure 4), especially in the case of F20CN and 
F19/20CN. In the intersheet stacking direction F19CN shows more stacking than the wild 
type, and F20CN shows significantly less. Both have an increase between sheets, but 
F20CN is more pronounced. In the hydrogen bonding direction only the F20CN has a 
significantly lower coherent length. (Figure 5)  
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Discussion 
 Alzheimer’s Disease is devastating, and the formation of inhibitors to Aβ fiber 
formation is an important step in the development of therapeutics. Peptide-based 
inhibitors have many valuable qualities and are able to provide insight into the 
mechanism and structure of fibrillogenesis and amyloid fibers. The hydrophobic core 
region Aβ(16-22) is a popular peptide for inhibition studies because it is the shortest 
fiber-forming Aβ segment and is key in the formation of fibers in the full-length 1-40 
peptide (14). 
 The methylation study confirms previous evidence that Aβ(16-22)m inhibits fiber 
formation. (18) There may have been a problem in the experimental procedure though. 
The sample preparation was not conducive to XRD experimentation. The dissolving of 
the wild type peptide and the inhibitor separately, and then combining them, allows the 
wild type to form fibers in the absence of inhibitor. The decrease in the degree of 
fibrillogenesis observed may then be the product of decreased Aβ(16-22) concentration 
as opposed to the interference of the methylated Aβ.  
 The results differ from previous viewpoints in the formation of structure by 
Aβ(16-22)m. It has been hypothesized that the methylated peptide does not bind to itself 
and cannot form fibers on its own (13, 14). From the XRD pattern (Figure 1:D) there is 
evidence of slight secondary structure.  Surprisingly, the darker band of the methylated 
peptide pattern is the hydrogen- bonding band. Hydrogen bonding is what has been 
predicted to be the most affected by methylation since they replace the open hydrogen 
atom with a methyl group. This may be explained by the presence of dimers, formed 
from hydrogen bonding between the faces of the peptide that are un-methylated. Also, 
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many researchers explain the process of inhibition as being mainly the product of 
hydrogen bonding interference, but there is no significant difference in the amount of 
hydrogen bonding in any sample from the methylation study, only in the amount of 
intersheet stacking. 
 The electron micrographs in Figure 3 provide morphological details to the 
structure of the peptide in the presence of inhibitor. Picture A is similar to previously 
published micrographs of Aβ(16-22) (19). Pictures B-D show the uniform, high density 
plate-like fibers formed from equal amounts of wild type Aβ(16-22) and inhibitor which 
have not been studied before. Their plate appearance is in accordance with the diffraction 
data. There was comparable hydrogen bonding in the wild type and inhibited samples, so 
flat fibers could still form. There was decreased intersheet stacking though, and therefore 
the hydrogen-bonded sheets did not interact and did not form fibrils like the 
unmethylated sample. 
 Since the cyanophenylalanine peptides were not tested with the wild type 
peptides, no insight was gained into their viability as a potential inhibitor. Instead, 
valuable structural information was revealed, including how the hydrophobic core 
functions in amyloid folding. This experiment presented further evidence that 
hydrophobic interactions are paramount in importance for fiber formation, and elucidated 
the vital role of F20 in such interactions. The addition of a cyanonitrile group to residue 
19 did not significantly decrease the amount of secondary structure; in fact it increased 
the amount of intersheet stacking, though the side-chain interactions resulted in greater 
spacing between β-sheets. The addition of a cyanonitrile group on the 20th residue, 
though, greatly decreased the amount of fiber formation. The wild type Aβ(16-22) 
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became ordered during the drying down phase when the peptide strands are able to 
rearrange to form their most stable conformation. In comparison to the lyophilized 
F20CN sample, the amount of secondary structure decreased with solubilization and 
drying. Given the time and space, these strands appear to repel each other and are unable 
to form any organized structure. These results correspond with the previous findings that 
Aβ(1-42) with an amino acid substitution on F20 decreases fibril formation and 
neurotoxicity. (20)  
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Conclusion 
 Methylated Aβ(16-22) does impact the extent of Aβ(16-22) fibrillogenesis. 
Though the coherent domain size in the hydrogen bonding direction does not vary greatly 
as the ratio of inhibitor to peptide increases, the domain size of the intersheet stacking 
decreases. This is supported by TEM and the plate-like fibers seen.  
Hydrophobic interactions play significant role in β sheet formation, and F20 is a 
vital part of this interaction. While a cyanonitrile substitution on phenylalanine 19 is also 
detrimental to fiber formation, one on 20 almost completely eliminates them. Substituting 
both phenylalanines denies all secondary structure. 
Further research should be done to assess the importance of F20 in longer peptide 
strains. It is unsurprising that it is influential in Aβ(16-22) since it is only a seven-residue 
fragment and makes up one hydrophobic core. Its efficacy of fiber prevention should be 
assessed using a peptide with more amino acids on either side of the core, such as Aβ(10-
35), and also on a peptide that encompasses both hydrophobic cores. Also, it should be 
tested as an inhibitor, mixed with a solution of wild-type Aβ(16-22) and the 
corresponding longer fragments.  
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                   A.  Aβ(16-22)                                             B. Aβ(16-22): Aβ(16-22)m 1:1 
     
           C. Aβ(16-22): Aβ(16-22)m 1:5                                 D. Aβ(16-22)m 
 
 
 
Figure 1: Background-subtracted XRD patterns of solubilized/ dried peptides for the 
methylation study. A decrease in the sharpness and darkness of bands is seen as the 
amount of methylated peptide increases. 
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Figure 2: Analysis of X-Ray Diffraction Patterns for Methylation Study  The points 
around 4.7 Å represent the hydrogen-bonding direction of fiber formation, and the points 
around 10.0 Å represent the intersheet stacking direction. While the hydrogen bonding 
did not differ significantly as the amount of inhibitor increased, the amount of intersheet 
stacking decreased as the amount of inhibitor increased. The lyophilized peptide is 
presented as a standard for comparison. 
 
 
 
 - 20 - 
 
             
 
                   A. Aβ(16-22)                                               B. 1:1 Aβ(16-22): Aβ(16-22)m 
 
              
 
         C. 1:1 Aβ(16-22): Aβ(16-22)m                             D. 1:1 Aβ(16-22): Aβ(16-22)m 
 
 
 
Figure 3: TEM micrographs of Aβ(16-22). Both figures 2.A and 2.B are taken at 39000x 
magnification. 2.C is taken at 28500x, and 2.D at 11500. B and C are pictures from the 
same grid to show the uniform density of the plate-like fibers. 
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                    A. Aβ(16-22)                                                B. Aβ(16-22) F19CN 
    
                 C. Aβ(16-22) F20CN                                       D. Aβ(16-22) F19/20CN 
 
 
Figure 4: Background-subtracted solubilized/dried XRD patterns of peptides for the 
cyanophenylalanine study. 20CN has a decrease in both hydrogen bonding and intersheet 
stacking compared to 19CN, and 19/20CN lacks a significant amount of ordered 
structure. 
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Figure 5: Analysis of X-Ray Diffraction Patterns for Cyanophenylalanine Study  
The 19 CN samples did not have a significant change in hydrogen bonding, and tended to 
increase the amount of intersheet stacking as compared to the wild type and its 
lyophilized form. There was an increase in the distance between sheets though. The 20 
CN samples showed decreases in both hydrogen bonding and intersheet stacking, plus a 
large change in the distance between sheets, as compared to the wild type and its 
lyophilized form. 
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Figure 6: Combined Data Points from Both X-Ray Diffraction Studies  The 
methylated peptides are more efficient at limiting intersheet stacking than the 19 CN- 
substituted peptide. 20 CN is significantly the most efficient, and the only peptide that 
limits hydrogen bonding. 
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Figure 7: Combined Data from Both X-Ray Diffraction Studies with Error The error 
bars represent the standard deviation from the arithmetic mean of each sample 
population. This more clearly shows the differences between samples, particularly the 
coherent lengths of the intersheet stacking direction of the fiber formation.  
 
 
 
 
